Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Myeloma, Newly Diagnosed”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Temporarily pausedNCT05199311
What this trial is testing

Carfilzomib, Iberdomide (CC-220) and Dexamethasone (KID) in Transplant Eligible Multiple Myeloma

Who this might be right for
Multiple Myeloma
Hackensack Meridian Health 66
Large-scale testing (Phase 3)UnknownNCT02362165
What this trial is testing

CyBorD vs. PAD in the Treatment of Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Sun Yat-sen University 236
Testing effectiveness (Phase 2)UnknownNCT05147493
What this trial is testing

Isatuximab in Combination With Bortezomib, Cyclophosphamide and Dexamethasone Followed by Isatuximab and Lenalidomide Maintenance in Newly Diagnosed Patients With Multiple Myeloma and Severe Renal Impairment

Who this might be right for
Multiple MyelomaRenal ImpairmentNeoplasms, Plasma Cell+5 more
Hellenic Society of Hematology 51
Early research (Phase 1)Active Not RecruitingNCT04091126
What this trial is testing

Study of Belantamab Mafodotin Plus Standard of Care (SoC) in Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
GlaxoSmithKline 118
Testing effectiveness (Phase 2)Ended earlyNCT04352205
What this trial is testing

Daratumumab-Based Therapy for the Treatment of Newly Diagnosed Multiple Myeloma With Kidney Failure

Who this might be right for
Plasma Cell MyelomaRenal Failure
Emory University 17
Large-scale testing (Phase 3)Looking for participantsNCT05243797
What this trial is testing

Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation

Who this might be right for
Multiple Myeloma
European Myeloma Network B.V. 1,594
Testing effectiveness (Phase 2)Study completedNCT01790737
What this trial is testing

First Line Treatment Trial in Multiple Myeloma, Finnish Myeloma Group- Multiple Myeloma 02

Who this might be right for
Multiple Myeloma
Kuopio University Hospital 80
Testing effectiveness (Phase 2)Looking for participantsNCT06140966
What this trial is testing

Study to Evaluate the Safety and Efficacy of Daratumumab and Carfilzomib-based Induction/Consolidation/Maintenance Therapy in Transplant-eligible, Ultra High-risk, Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple MyelomaPrimary Plasma Cell LeukemiaExtramedullary Multiple Myeloma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 54
Not applicableLooking for participantsNCT06682156
What this trial is testing

Conversion to Carfilzomib Therapy in Bortezomib Intolerant Newly Diagnosed Multiple Myeloma(NDMM) Patients

Who this might be right for
Newly Diagnosed Multiple Myeloma
The First Affiliated Hospital of Soochow University 50
Testing effectiveness (Phase 2)Study completedNCT00024466
What this trial is testing

Chemotherapy, Vaccine Therapy, and Stem Cell Transplantation in Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 28
Testing effectiveness (Phase 2)Study completedNCT01029054
What this trial is testing

Carfilzomib and Lenalidomide With Dexamethasone Combination in Newly Diagnosed, Previously Untreated Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Michigan Rogel Cancer Center 53
Testing effectiveness (Phase 2)UnknownNCT01812096
What this trial is testing

Study of Subcutaneous Versus Intravenous Administration of Bortezomib in Patients With Multiple Myeloma in China

Who this might be right for
Multiple Myeloma Proved by Laboratory Tests
The First Affiliated Hospital of Soochow University 20
Large-scale testing (Phase 3)Ended earlyNCT00644306
What this trial is testing

Comparison of Melphalan-Prednisone (MP) to MP Plus Thalidomide in the Treatment of Newly Diagnosed Very Elderly Patients (> 75 Years) With Multiple Myeloma

Who this might be right for
Newly Diagnosed, Multiple Myeloma
Central Hospital, Nancy, France 232
Testing effectiveness (Phase 2)Study completedNCT00531453
What this trial is testing

Evaluate Two Different Regimens of VELCADE in Combination With Dexamethasone, Thalidomide and Cyclophosphamide (VDT vs VDTC) in Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Millennium Pharmaceuticals, Inc. 98
Large-scale testing (Phase 3)Study completedNCT00405756
What this trial is testing

Compare MPR With MP in Newly Diagnosed Multiple Myeloma Subjects 65 Years Old or Older.

Who this might be right for
Newly Diagnosed Multiple Myeloma
Celgene Corporation 459
Testing effectiveness (Phase 2)Study completedNCT01706666
What this trial is testing

Bortezomib Based Consolidation in Multiple Myeloma Patients Completing Stem Cell Transplant

Who this might be right for
Stage I Multiple MyelomaStage II Multiple MyelomaStage III Multiple Myeloma
Mayo Clinic 3
Testing effectiveness (Phase 2)WithdrawnNCT02802163
What this trial is testing

Induction Therapy for Multiple Myeloma With Carfilzomib, Lenalidomide,Dexamethasone,Panobinostat

Who this might be right for
Multiple Myeloma
H. Lee Moffitt Cancer Center and Research Institute
Not applicableUnknownNCT03089411
What this trial is testing

Collection of Additional Data Followed the Study IFM 2013-04

Who this might be right for
Myeloma Multiple
Nantes University Hospital 340
Not applicableLooking for participantsNCT06698887
What this trial is testing

Evaluate the Long-Term Safety of Idecabtagene Vicleucel Treatment in Adults With Newly Diagnosed Multiple Myeloma in Korea

Who this might be right for
Multiple Myeloma
Bristol-Myers Squibb 15
Not applicableActive Not RecruitingNCT05889221
What this trial is testing

Multicenter Phase 2 Study of Subcutaneous Isatuximab Plus Bortezomib, Lenalidomide and Dexamethasone in the Treatment of Newly Diagnosed Transplant Ineligible Multiple Myeloma

Who this might be right for
Multiple MyelomaMyeloma MultipleMyeloma
Poitiers University Hospital 74
Next Page